JY
ACHV icon

Jeff Yass’s Achieve Life Sciences ACHV Stock Holding History

Jeff Yass’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$677K Buy
103,700
+61,400
+145% +$293K ﹤0.01% 9189
2026
Q1 		$124K Buy
42,300
+18,600
+78% +$82.6K ﹤0.01% 12190
2025
Q4 		$118K Buy
23,700
+4,000
+20% +$17.4K ﹤0.01% 11357
2025
Q3 		$62.1K Buy
+19,700
New +$54.1K ﹤0.01% 11791
2024
Q2 		– Sell
-16,100
Closed -$73.3K – 11920
2024
Q1 		$73.3K Sell
16,100
-14,700
-48% -$65.3K ﹤0.01% 11382
2023
Q4 		$127K Buy
30,800
+1,800
+6% +$7.84K ﹤0.01% 11131
2023
Q3 		$125K Buy
29,000
+4,500
+18% +$22.7K ﹤0.01% 10734
2023
Q2 		$127K Sell
24,500
-25,500
-51% -$179K ﹤0.01% 10741
2023
Q1 		$340K Buy
50,000
+39,100
+359% +$186K ﹤0.01% 9457
2022
Q4 		$26.9K Buy
+10,900
New +$28K ﹤0.01% 11655
2022
Q2 		– Sell
-15,100
Closed -$114K – 12765
2022
Q1 		$114K Buy
+15,100
New +$112K ﹤0.01% 11804
2015
Q3 		– Sell
-5
Closed -$25K – 9570
2015
Q2 		$25K Buy
+5
New +$24.8K ﹤0.01% 9978
2015
Q1 		– Sell
-32
Closed -$159K – 9342
2014
Q4 		$159K Sell
32
-28
-47% -$137K ﹤0.01% 8974
2014
Q3 		$353K Sell
60
-52
-46% -$361K ﹤0.01% 7772
2014
Q2 		$923K Hold
112
– – ﹤0.01% 6217
2014
Q1 		$2.9M Buy
112
+95
+559% +$2.33M ﹤0.01% 3706
2013
Q4 		$314K Buy
17
+10
+143% +$175K ﹤0.01% 7512
2013
Q3 		$144K Buy
+7
New +$145K ﹤0.01% 7933

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Jeff Yass's ACHV Position: Q2 2026 in Review

Jeff Yass reduced its Achieve Life Sciences (ACHV) stake by 92% in Q2 2026, selling an estimated $1.68M and leaving 30,372 shares worth $198K. The position accounts for ﹤0.01% of the portfolio, ranked #11961.

Jeff Yass first reported a position in ACHV in Q4 2013 and has held it in 31 quarters since. The position peaked at $2.47M in Q4 2025. 110 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Jeff Yass held 30,372 shares of Achieve Life Sciences worth $198K as of Q2 2026.
  • Jeff Yass sold 353,311 Achieve Life Sciences shares in Q2 2026, an estimated $1.68M.
  • Achieve Life Sciences made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #11961 holding.
  • Jeff Yass first reported a position in Achieve Life Sciences in Q4 2013 and has held it in 31 quarters since.
  • Jeff Yass's Achieve Life Sciences position peaked at $2.47M in Q4 2025.
  • 110 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.